1. Metformin as Potential Therapy for High-Grade Glioma
   Marek Mazurek et al, 2020, Cancers CrossRef
2. Elevated de novo protein synthesis in FMRP-deficient human neurons and its correction by metformin treatment
   Kagistia Hana Utami et al, 2020, Molecular Autism CrossRef
3. Autophagy as a Potential Therapy for Malignant Glioma
   Angel Escamilla-Ramírez et al, 2020, Pharmaceuticals CrossRef
4. The Role of AMPK/mTOR Signaling Pathway in Anticancer Activity of Metformin
   Nikola Chomanicova et al, 2021, Physiol Res CrossRef
5. Glioma Stem-Like Cells and Metabolism: Potential for Novel Therapeutic Strategies
   Abigail Harland et al, 2021, Front. Oncol. CrossRef
6. Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma
   Laura Guarnaccia et al, 2021, Cancers CrossRef
7. Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies
   Lindsay Joyce Nitsche et al, 2022, Cancers CrossRef
8. Canagliflozin Inhibits Glioblastoma Growth and Proliferation by Activating AMPK
   Kenji Shoda et al, 2022, Cell Mol Neurobiol CrossRef
9. Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin
   Shao-Wei Feng et al, 2022, IJMS CrossRef
10. The Potential Therapeutic Impact of Metformin in Glioblastoma Multiforme
    Mehdi Sanati et al, 2023, CMC CrossRef
11. Metformin use is associated with longer survival in glioblastoma patients with MGMT gene silencing
    Amro H. Mohammad et al, 2023, J Neurooncol CrossRef
12. Role of renin angiotensin system inhibitors and metformin in Glioblastoma Therapy: a review
    Sashana Dixon et al, 2024, Cancer Chemother Pharmacol CrossRef